Mark For: CONTINGENT PRODUCT RIGHTS™ trademark registration is intended to cover the category of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 90517903 |
Mark Literal Elements | CONTINGENT PRODUCT RIGHTS |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Service Mark |
Current Location | NEW APPLICATION PROCESSING 2021-02-11 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Steven R. Goldberg |
2021-02-08 | Application Filed |
2021-02-11 | Location: NEW APPLICATION PROCESSING |
2021-02-11 | Status: Live/Pending |
2021-02-11 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
2021-02-11 | Transaction Date |
Party: | ![]() |
Address | 301 West 41st St., Suite 300 Miami Beach, FLORIDA UNITED STATES 33140 |
Legal Entity Type | Corporation |
Legal Entity State | FLORIDA |
![]() | MULTI | 2021-02-08 |
![]() | JPEG | 2021-02-08 |
International Codes: | 36 |
U.S. Codes: | 100,101,102 |
Type Code | Type |
---|---|
GS0361 | A non-equity dilutive form of financing whereby a person receives rights from a pharmaceutical or other such similar companies to a predesignated number of dosages of medicine or other medicinal products developed by pharmaceutical or other such similar companies if and when such products are approved by the Federal Drug Administration or such other governmental organization responsible for approving the medicinal product |
GS0361 | Financing services in the nature of a non-equity dilutive form of financing whereby an individual investor finances a pharmaceutical company for the company's development of medicine in exchange for rights from the pharmaceutical company to a predesignated number of dosages of the medicine developed from the utilization of the financing upon Federal Drug Administration approval of the medicine |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2021-02-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.